New diabetes drug shows promise in early trial
NCT ID NCT00497198
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 14 times
Summary
This study tested an experimental drug called MCI-196 in 183 adults with type 2 diabetes. Over 12 weeks, researchers measured how well it controlled blood sugar and checked for side effects. They also looked at its effect on cholesterol levels. The goal was to see if MCI-196 could help manage diabetes better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.